![](/img/cover-not-exists.png)
1482OOutcomes with pembrolizumab (pembro) monotherapy in patients (pts) with PD-L1–positive NSCLC with brain metastases: Pooled analysis of KEYNOTE-001, -010, -024, and -042
Mansfield, A S, Herbst, R S, Castro, G, Hui, R, Peled, N, Kim, D-W, Novello, S, Satouchi, M, Wu, Y-L, Garon, E B, Reck, M, Robinson, A G, Samkari, A, Piperdi, B, Ebiana, V, Lin, J, Mok, T S KVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz260.004
Date:
October, 2019
File:
PDF, 111 KB
2019